Synthpop, a healthcare AI company focused on agentic automation for payer, provider, and patient operations, raised a $15 million in Series A funding to scale automation across administrative workflows throughout the patient journey. The financing brings Synthpop’s total funding to $23 million.
The round was led by Ansa Capital, and Ansa Co-Founder and Managing Partner Marco DeMeireles will join Synthpop’s board of directors. Defy.vc and Peterson Ventures participated, alongside Storm Ventures and strategic investor Bruce Broussard.
Synthpop says its platform combines document intelligence, payer-aware reasoning, conversational voice agents, and an orchestration layer into a coordinated system designed to automate administrative work tied to referrals, prior authorizations, eligibility checks, claims follow-ups, and patient access. The company positions its product as an integration-friendly layer that connects directly with EHR, billing, and e-prescribe platforms to reduce denials, lower costs, and accelerate care delivery while maintaining compliance and transparency.
The company reported operational metrics that it says demonstrate traction over the past year, including processing more than 2 million patients and integrating with eight major EHR systems. Synthpop also said customers are using the system to compress workflows that historically took about 40 minutes into under a minute, at a fraction of the cost of traditional labor.
Synthpop said the funding follows the recent addition of the airt team, led by Davor Runje and Hajdi Cenan, to accelerate its AI workflow capabilities. The company plans to use the new capital to expand its team, deepen product capabilities and integrations, and broaden coverage into additional healthcare verticals.
Synthpop said it is SOC 2 audited and HIPAA compliant. The company was founded in 2023 by CEO Elad Ferber and CTO Jan Jannink, PhD.
KEY QUOTES
“Point solutions can’t fix operational bottlenecks. Providers need a unified system that understands insurance requirements, handles phone calls naturally, and works seamlessly with their existing software.”
Elad Ferber, Chief Executive Officer, Synthpop
“Point solutions can’t fix operational bottlenecks. Providers need a unified system that understands insurance requirements, handles phone calls naturally, and works seamlessly with their existing software. This funding helps us expand our coverage and deepen integrations so providers can scale their operations and expand access to care.”
Elad Ferber, Chief Executive Officer, Synthpop
“Healthcare organizations have long been constrained by highly manual workflows and human capital bottlenecks. AI-native solutions like Synthpop are the only way for them to fulfill rising demand and increased patient expectations. The early value delivered to customers has been extremely compelling; I’m thrilled to join the Board and partner with Elad and the Synthpop team.”
Marco DeMeireles, Co Founder and Managing Partner, Ansa Capital
“Synthpop stood out to us for its ability to automate complex, real-world healthcare workflows with speed, accuracy, and compliance. We’ve been impressed by their progress as investors, and we’re excited to double down. Their multi-agent platform delivers immediate, measurable value for providers, dramatically reducing time, cost, and friction across the patient journey. With strong customer adoption and a world-class technical team, we believe Synthpop is building critical infrastructure for a more efficient, human-centered healthcare system, and we’re excited to support a mission that ultimately helps speed up and improve access to care for patients.”
Medha Agarwal, General Partner, Defy.vc
